
Accolade ACCD
Quarterly report 2024-Q4
added 01-10-2025
Accolade Operating Income 2011-2026 | ACCD
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Accolade
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -46.8 M | -48.2 M | -54 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -46.8 M | -54 M | -49.7 M |
Quarterly Operating Income Accolade
| 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -122 M | -25.1 M | -29 M | - | -31.7 M | -35.2 M | -39.6 M | - | -40.4 M | -45.9 M | -346 M | - | 26.5 M | -95.9 M | -122 M | -48 M | -16.5 M | -16.5 M | -12.9 M | -12.6 M | -17.4 M | -14.3 M | -15.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 26.5 M | -346 M | -53 M |
Operating Income of other stocks in the Health information services industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cerner Corporation
CERN
|
708 M | - | - | $ 27.9 B | ||
|
Change Healthcare
CHNG
|
137 M | - | - | $ 9.03 B | ||
|
Computer Programs and Systems
CPSI
|
-42.6 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
-23 M | - | - | $ 2.94 B | ||
|
Evolent Health
EVH
|
3.64 M | $ 4.1 | 1.99 % | $ 384 M | ||
|
Health Catalyst
HCAT
|
-69.8 M | $ 2.48 | 3.99 % | $ 149 M | ||
|
iCAD
ICAD
|
-6.27 M | - | - | $ 102 M | ||
|
HealthStream
HSTM
|
21.3 M | $ 22.67 | -2.07 % | $ 689 M | ||
|
Akerna Corp.
KERN
|
-17.7 M | - | - | $ 161 M | ||
|
HealthEquity
HQY
|
118 M | $ 97.34 | 1.97 % | $ 8.33 B | ||
|
American Well Corporation
AMWL
|
-218 M | $ 5.11 | -4.49 % | $ 76.6 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
77.2 M | - | -10.39 % | $ 886 M | ||
|
MTBC
MTBC
|
9.12 M | - | -0.58 % | $ 51.7 M | ||
|
GoodRx Holdings
GDRX
|
65.8 M | $ 2.89 | -0.34 % | $ 1.11 B | ||
|
OptimizeRx Corporation
OPRX
|
-26.4 M | $ 13.88 | 4.2 % | $ 238 M | ||
|
Omnicell
OMCL
|
337 K | $ 47.55 | 1.02 % | $ 2.19 B | ||
|
1Life Healthcare
ONEM
|
-243 M | - | - | $ 3.37 B | ||
|
So-Young International
SY
|
-624 M | $ 2.55 | -3.6 % | $ 202 M | ||
|
Progyny
PGNY
|
15.8 M | $ 26.68 | 0.04 % | $ 2.29 B | ||
|
Phreesia
PHR
|
-136 M | $ 17.53 | 1.8 % | $ 956 M | ||
|
Premier
PINC
|
1.12 M | $ 28.26 | - | $ 2.33 B | ||
|
R1 RCM
RCM
|
146 M | - | - | $ 3.81 B | ||
|
Veeva Systems
VEEV
|
429 M | $ 239.12 | 0.45 % | $ 38.4 B | ||
|
NantHealth
NH
|
-51.3 M | - | -46.64 % | $ 10.4 M | ||
|
Zhongchao
ZCMD
|
-341 K | $ 0.5 | -4.6 % | $ 2.6 M | ||
|
NextGen Healthcare
NXGN
|
12.8 M | - | - | $ 1.6 B | ||
|
Schrödinger
SDGR
|
-209 M | $ 18.77 | 0.03 % | $ 1.36 B | ||
|
Signify Health
SGFY
|
9.5 M | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
-8.03 M | - | - | $ 21.4 M | ||
|
10x Genomics
TXG
|
-265 M | $ 19.88 | 2.93 % | $ 2.33 B | ||
|
Teladoc Health
TDOC
|
-1.02 B | $ 7.6 | -5.06 % | $ 1.3 B | ||
|
Tabula Rasa HealthCare
TRHC
|
-69 M | - | - | $ 255 M | ||
|
SCWorx Corp.
WORX
|
-1.26 M | $ 0.2 | -3.49 % | $ 292 K |